NervGen Pharma
A medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
AUD201m
Enterprise valuation
AUD171m (Public information from Sep 2024)
Share price
$2.006 NGENF
Vancouver British Columbia (HQ)
Authorizing premium user...